Investment Firm
Overview
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Feb 03, 2022
Debt Financing
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
1
Investor Name |
---|
Karolinska |
AnaCardio raised $3626423 on 2022-02-03 in Debt Financing
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Company Funding History
3
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Sep 07, 2022 | Series A - AnaCardio | 3 | - | 14.0M |
Feb 03, 2022 | Debt Financing - AnaCardio | 4 | - | 3.6M |
Jun 17, 2021 | Seed Round - AnaCardio | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.